• Home
  • NEW DAY MEDICINE
  • 6 (92) 2026
  • 129 -6 (92) 2026 - Aripov A.N., Aripov O.A., Xojimurod M.M., Toshev I.N., Ayubov B.F., Zokirov D.D. - TRANSFORMATION OF THE FINANCIAL RESOURCE STRUCTURE IN THE CENTRALIZATION OF CLINICAL DIAGNOSTIC LABORATORY SERVICES: A SHIFT FROM SALARIES TO DIAGNOSTICS

129 -6 (92) 2026 - Aripov A.N., Aripov O.A., Xojimurod M.M., Toshev I.N., Ayubov B.F., Zokirov D.D. - TRANSFORMATION OF THE FINANCIAL RESOURCE STRUCTURE IN THE CENTRALIZATION OF CLINICAL DIAGNOSTIC LABORATORY SERVICES: A SHIFT FROM SALARIES TO DIAGNOSTICS

TRANSFORMATION OF THE FINANCIAL RESOURCE STRUCTURE IN THE CENTRALIZATION OF CLINICAL DIAGNOSTIC LABORATORY SERVICES: A SHIFT FROM SALARIES TO DIAGNOSTICS

Aripov A.N. - Center for the Development of Professional Qualifications of Medical Workers under the Ministry of Health of the Republic of Uzbekistan

Aripov O.A. - "Tashkent City Medical Consultative Diagnostic Center" DM "Central Laboratory"

Xojimurod M.M. - "Tashkent City Medical Consultative Diagnostic Center" DM "Central Laboratory"

Toshev I.N. - "Tashkent City Medical Consultative Diagnostic Center" DM "Central Laboratory"

Ayubov B.F. - "Tashkent City Medical Consultative Diagnostic Center" DM "Central Laboratory"

Zokirov D.D. - "Tashkent City Medical Consultative Diagnostic Center" DM "Central Laboratory"

Resume

Aim. To analyse the transformation of the financial resource structure of clinical diagnostic laboratory services following their centralization, based on the experience of the «Central Laboratory» pilot project in the Yashnobod district of Tashkent. Materials and methods. A comparative economic analysis was performed using the financial and statistical reports of the laboratory units of primary health care institutions for 2022–2024 (pre-centralization period) and of the Central Laboratory for the year 2025 (post-centralization period). The structure of allocated funds, the volume of performed analyses and the average cost per test were compared. Results. Before centralization, 80–85% of the allocated funds were spent on staff salaries and the unified social payment, and only 13–15% on reagents and consumables, with no funds allocated for equipment. After centralization, the combined share of salary and social payment fell to 36.0%, whereas expenditure on reagents and consumables rose to 63.6%. Despite the transition to automated analysers, chemiluminescent immunoassay and an ISO 15189-based quality management system, the average cost per test increased only moderately, from 3,085 to 3,615 UZS. Conclusion. Centralization redirects financial resources from staff maintenance toward actual diagnostics and achieves a substantial qualitative upgrade of laboratory services at a stable unit cost.

Keywords: clinical laboratory, centralization, consolidation, laboratory economics, cost per test, automation, primary health care.

First page

792

Last page

787

For citation:Aripov A.N., Aripov O.A., Xojimurod M.M., Toshev I.N., Ayubov B.F., Zokirov D.D. - TRANSFORMATION OF THE FINANCIAL RESOURCE STRUCTURE IN THE CENTRALIZATION OF CLINICAL DIAGNOSTIC LABORATORY SERVICES: A SHIFT FROM SALARIES TO DIAGNOSTICS//New Day in Medicine 6(92)2026 787-792 https://newdayworldmedicine.com/en/new_day_medicine/6-92-2026

List of References

  1. World Health Organization. Laboratory diagnostics and public health: Strategy 2021–2030. Geneva: World Health Organization; 2021. p. 15–22.
  2. Lippi G, Plebani M. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clin Chem Lab Med. 2020;58(7):1063–1069. doi: 10.1515/cclm-2020-0240.
  3. Greaves RF, Bernardini S, Ferrari M, et al. Key questions about the future of laboratory medicine in the next decade of the 21st century: A report from the IFCC-Emerging Technologies Division. Clin Chim Acta. 2019;495:570–589. doi: 10.1016/j.cca.2019.05.021.
  4. Lamovsek N, Klun M, Skitek M, Bencina J. Defining the optimal size of medical laboratories at the primary level of health care with data envelopment analysis. Acta Inform Med. 2019;27(4):224–228. doi: 10.5455/aim.2019.27.224-228.
  5. Cook J. Laboratory integration and consolidation in a regional health system. Lab Med. 2017;48(3):e43–e52. doi: 10.1093/labmed/lmx020.
  6. Church DL, Naugler C. Using a systematic approach to strategic innovation in laboratory medicine to bring about change. Crit Rev Clin Lab Sci. 2022;59(3):178–202. doi: 10.1080/10408363.2021.1983504.
  7. Panteghini M. Redesigning the surveillance of in vitro diagnostic medical devices and medical laboratory performance by quality control in the traceability era. Clin Chem Lab Med. 2023;61(5):759–768. doi: 10.1515/cclm-2022-1162.
  8. Mouseli A, Barouni M, Amiresmaili M, et al. Measuring the net profit of laboratory services: A case study in Iran. Med J Islam Repub Iran. 2018;32:12. doi: 10.14196/mjiri.32.12.
  9. Alinejhad M, Aghlmand S, Feizollahzadeh S, Yusefzadeh H. The economic efficiency of clinical laboratories in public hospitals: A case study in Iran. J Clin Lab Anal. 2019;33(5):e23067. doi: 10.1002/jcla.23067.
  10. Кочетов АГ, Лянг ОВ. Актуальные проблемы организации лабораторной службы в Российской Федерации. Москва: У Никитских ворот; 2016. 144 с.

    file

    download